Vanguard · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
Vanguard Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 56.3M | $18.9B | — |
| 2024Q2 | 29.4M | $11.0B | -41.7% |
| 2024Q3 | 29.9M | $11.0B | +0.3% |
| 2024Q4 | 30.1M | $9.7B | -11.8% |
| 2025Q1 | 30.4M | $11.6B | +19.5% |
| 2025Q2 | 31.7M | $10.9B | -5.9% |
| 2025Q3 | 32.6M | $9.7B | -11.4% |
| 2025Q4 | 32.5M | $11.1B | +14.5% |
| 2026Q1 | 52.2M | $18.3B | +64.8% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F